NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 03/28/22 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
   |
159 |
| 03/24/22 | 8-K | Current report filing |
|
|
6 |
| 02/11/22 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 | |
| 01/13/22 | 8-K | Current report filing |
|
|
28 |
| 12/16/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
87 |
| 12/10/21 | 8-K | Current report filing |
|
6 | |
| 11/29/21 | SEC STAFF LETTER | SEC Staff Letter |
|
1 | |
| 11/26/21 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 11/26/21 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 11/26/21 | 3 | Initial statement of beneficial ownership of securities |
|
1 |